vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Sonos Inc (SONO). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $545.7M, roughly 1.4× Sonos Inc). Sonos Inc runs the higher net margin — 17.2% vs 3.6%, a 13.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -0.9%). Over the past eight quarters, Sonos Inc's revenue compounded faster (47.0% CAGR vs 45.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Sonos, Inc. is an American audio equipment manufacturer headquartered in Santa Barbara, California. The company was founded in 2002 by John MacFarlane, Craig Shelburne, Tom Cullen, and Trung Mai.

CLOV vs SONO — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.4× larger
CLOV
$749.2M
$545.7M
SONO
Growing faster (revenue YoY)
CLOV
CLOV
+63.0% gap
CLOV
62.0%
-0.9%
SONO
Higher net margin
SONO
SONO
13.5% more per $
SONO
17.2%
3.6%
CLOV
Faster 2-yr revenue CAGR
SONO
SONO
Annualised
SONO
47.0%
45.0%
CLOV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
SONO
SONO
Revenue
$749.2M
$545.7M
Net Profit
$27.3M
$93.8M
Gross Margin
46.5%
Operating Margin
3.6%
18.4%
Net Margin
3.6%
17.2%
Revenue YoY
62.0%
-0.9%
Net Profit YoY
86.7%
EPS (diluted)
$0.05
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SONO
SONO
Q1 26
$749.2M
Q4 25
$487.7M
$545.7M
Q3 25
$496.6M
$287.9M
Q2 25
$477.6M
$344.8M
Q1 25
$462.3M
$259.8M
Q4 24
$337.0M
$550.9M
Q3 24
$331.0M
$255.4M
Q2 24
$356.3M
$397.1M
Net Profit
CLOV
CLOV
SONO
SONO
Q1 26
$27.3M
Q4 25
$-49.3M
$93.8M
Q3 25
$-24.4M
$-37.9M
Q2 25
$-10.6M
$-3.4M
Q1 25
$-1.3M
$-70.1M
Q4 24
$-22.1M
$50.2M
Q3 24
$-9.2M
$-53.1M
Q2 24
$7.4M
$3.7M
Gross Margin
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
46.5%
Q3 25
43.7%
Q2 25
43.4%
Q1 25
43.7%
Q4 24
43.8%
Q3 24
24.5%
40.3%
Q2 24
30.3%
48.3%
Operating Margin
CLOV
CLOV
SONO
SONO
Q1 26
3.6%
Q4 25
-10.1%
18.4%
Q3 25
-4.9%
-12.0%
Q2 25
-2.2%
-0.8%
Q1 25
-0.3%
-23.6%
Q4 24
-6.4%
8.7%
Q3 24
-2.7%
-27.2%
Q2 24
2.0%
3.2%
Net Margin
CLOV
CLOV
SONO
SONO
Q1 26
3.6%
Q4 25
-10.1%
17.2%
Q3 25
-4.9%
-13.1%
Q2 25
-2.2%
-1.0%
Q1 25
-0.3%
-27.0%
Q4 24
-6.6%
9.1%
Q3 24
-2.8%
-20.8%
Q2 24
2.1%
0.9%
EPS (diluted)
CLOV
CLOV
SONO
SONO
Q1 26
$0.05
Q4 25
$0.75
Q3 25
$-0.30
Q2 25
$-0.03
Q1 25
$-0.58
Q4 24
$0.40
Q3 24
$-0.42
Q2 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SONO
SONO
Cash + ST InvestmentsLiquidity on hand
$177.6M
$312.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$443.3M
Total Assets
$697.7M
$947.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SONO
SONO
Q1 26
$177.6M
Q4 25
$78.3M
$312.5M
Q3 25
$174.7M
Q2 25
$201.3M
Q1 25
$173.2M
Q4 24
$194.5M
$280.0M
Q3 24
$288.0M
$169.7M
Q2 24
$254.8M
$227.1M
Stockholders' Equity
CLOV
CLOV
SONO
SONO
Q1 26
$339.4M
Q4 25
$308.7M
$443.3M
Q3 25
$340.9M
$355.2M
Q2 25
$344.2M
$399.3M
Q1 25
$336.1M
$382.9M
Q4 24
$341.1M
$469.1M
Q3 24
$342.2M
$428.6M
Q2 24
$324.9M
$464.4M
Total Assets
CLOV
CLOV
SONO
SONO
Q1 26
$697.7M
Q4 25
$541.0M
$947.9M
Q3 25
$559.7M
$823.3M
Q2 25
$575.0M
$834.4M
Q1 25
$583.7M
$792.2M
Q4 24
$580.7M
$963.6M
Q3 24
$653.0M
$916.3M
Q2 24
$674.2M
$961.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SONO
SONO
Operating Cash FlowLast quarter
$163.3M
Free Cash FlowOCF − Capex
$157.3M
FCF MarginFCF / Revenue
28.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.74×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
$-66.9M
$163.3M
Q3 25
$12.1M
$2.9M
Q2 25
$5.4M
$37.4M
Q1 25
$-16.3M
$-59.7M
Q4 24
$34.8M
$156.2M
Q3 24
$50.0M
$-37.7M
Q2 24
$44.8M
$63.5M
Free Cash Flow
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
$-69.0M
$157.3M
Q3 25
$11.4M
Q2 25
$4.8M
$32.7M
Q1 25
$-16.5M
$-65.2M
Q4 24
$33.3M
$143.1M
Q3 24
$49.6M
Q2 24
$44.4M
$40.3M
FCF Margin
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
-14.1%
28.8%
Q3 25
2.3%
Q2 25
1.0%
9.5%
Q1 25
-3.6%
-25.1%
Q4 24
9.9%
26.0%
Q3 24
15.0%
Q2 24
12.5%
10.1%
Capex Intensity
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
1.4%
Q1 25
0.0%
2.1%
Q4 24
0.5%
2.4%
Q3 24
0.1%
Q2 24
0.1%
5.8%
Cash Conversion
CLOV
CLOV
SONO
SONO
Q1 26
Q4 25
1.74×
Q3 25
Q2 25
Q1 25
Q4 24
3.11×
Q3 24
Q2 24
6.04×
17.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SONO
SONO

Sonos speakers$459.2M84%
Sonos system products$65.1M12%
Partner products and other revenue$21.4M4%

Related Comparisons